Corrado Campochiaro

83PUBLICATIONS
309CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyPsychiatry (incl. psychotherapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (83)

|Oct 07, 2026
MEK inhibition achieves robust and durable responses in Erdheim-Chester disease.

|Sep 28, 2026
Comparative Effectiveness of Tocilizumab and Tumor Necrosis Factor Inhibitors in Takayasu Arteritis: Age-Related Differences in Treatment Response.

|Jun 09, 2026
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian study.

|Jun 01, 2026
Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis.

|May 13, 2026
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.

|Apr 08, 2026
Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR database.

Aslihan Avanoglu-Guler, Michael Hughes, Giacomo De Luca

Pageof 14

Frequent Collaborators

28 joint publications

Alessandro Tomelleri

20 joint publications

Lorenzo Dagna

17 joint publications

Giacomo De Luca

8 joint publications

Simone Sala